A detailed history of Logos Global Management LP transactions in Io Biotech, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 493,827 shares of IOBT stock, worth $380,246. This represents 0.07% of its overall portfolio holdings.

Number of Shares
493,827
Previous 493,827 -0.0%
Holding current value
$380,246
Previous $577,000 10.23%
% of portfolio
0.07%
Previous 0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$1.28 - $2.03 $632,098 - $1 Million
493,827 New
493,827 $696,000

Others Institutions Holding IOBT

About IO Biotech, Inc.


  • Ticker IOBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,815,300
  • Market Cap $22.2M
  • Description
  • IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...
More about IOBT
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.